No Reduction in WMH Progression With Allopurinol After Stroke No Reduction in WMH Progression With Allopurinol After Stroke

Use of allopurinol, a xanthine oxidase inhibitor, did not reduce progression of white matter hyperintensity (WMH) after stroke in a randomized trial.Medscape Medical News
Source: Medscape FamilyMedicine Headlines - Category: Primary Care Tags: Neurology & Neurosurgery News Source Type: news